Xcout IntelSign inSubscribe

OCON Therapeutics

Medical DevicesIsrael

OCON Therapeutics is a medical device company founded in 2011 and headquartered in Modiin, Israel, dedicated to creating new standards of care for women's health.

Subscribe to see OCON Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

OCON Therapeutics at a glance

OCON Therapeutics is a medical devices company headquartered in Israel. Xcout tracks 18 named people at OCON Therapeutics, including Keren Leshem (Chief Executive Officer).

Industry
Medical Devices
Headquarters
Israel

OCON Therapeutics leadership

  • Keren LeshemChief Executive Officer
  • Amir AvrahamCFO & General Manager
  • Prof. Sergio HaimovichChief Medical Officer
  • Adely LevyVP RA/QA
  • Daniel SclarVP Operations
  • Daniela SchardingerVP Marketing & Medical Affairs

12 more named people on record for OCON Therapeutics, with roles, board committees and tenure — see the full roster →

OCON Therapeutics competitors

A few of OCON Therapeutics's closest competitors — see the full list of competitors and alternatives →

Get OCON Therapeutics's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

OCON Therapeutics — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on OCON Therapeutics in Xcout Intel

  • 18 named people with titles, LinkedIn and board committees
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →